Boston, MA
Join Ncardia at this year’s BIO International Convention to discover how our full-service iPSC solutions can help you reduce risk, streamline development and make more confident therapeutic decisions.
The Ncardia team will be on-site, ready to discuss how our iPSC-derived platforms are reshaping preclinical drug development.
Whether you’re advancing discovery, enhancing safety or scaling regenerative medicine efforts, Ncardia’s human-relevant models and expert support accelerate your path to the clinic.
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.